Center-Authored Papers

Filters: Author is Elharrar, Vanessa  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Tieu H-V, Liu T-Y, Hussen S, Connor M, Wang L, Buchbinder S, Wilton L, Gorbach P, Mayer K, Griffith S et al..  2015.  Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities.. PloS one. 10(8):e0134085. Abstract
P
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS et al..  2011.  Prevention of HIV-1 infection with early antiretroviral therapy.. The New England journal of medicine. 365(6):493-505. Abstract
L
Riddler SA, Husnik M, Gorbach PM, Levy L, Parikh U, Livant E, Pather A, Makanani B, Muhlanga F, Kasaro M et al..  2016.  Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges in MTN-015.. HIV clinical trials. :1-8. Abstract
H
Riddler SA, Husnik M, Ramjee G, Premrajh A, Tutshana BO, Pather A, Siva S, Jeenarain N, Nair G, Selepe P et al..  2017.  HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.. PloS one. 12(6):e0178594. Abstract
F
Safren SA, Hughes JP, Mimiaga MJ, Moore AT, Friedman RK, Srithanaviboonchai K, Limbada M, Williamson BD, Elharrar V, Cummings V et al..  2016.  Frequency and predictors of estimated HIV transmissions and bacterial STI acquisition among HIV-positive patients in HIV care across three continents.. Journal of the International AIDS Society. 19(1):21096. Abstract
El-Sadr WM, Donnell D, Beauchamp G, Hall IH, Torian LV, Zingman B, Lum G, Kharfen M, Elion R, Leider J et al..  2017.  Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).. JAMA internal medicine. Abstract
D
Hendrix CW, Andrade A, Bumpus NN, Kashuba A, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I et al..  2015.  Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine after Directly Observed Dosing in Healthy Volunteers to establish Adherence Benchmarks (HPTN 066).. AIDS research and human retroviruses. Abstract
C
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L et al..  2013.  Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061.. PloS one. 8(7):e70413. Abstract
A
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS et al..  2016.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.. The New England journal of medicine. 375(9):830-9. Abstract
Magidson JF, Li X, Mimiaga MJ, Moore AT, Srithanaviboonchai K, Friedman RK, Limbada M, Hughes JP, Cummings V, Gaydos CA et al..  2015.  Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings.. AIDS and behavior. Abstract